a
Exploring the allergy world with the BSACI

If this new national allergy strategy is the map, then Goal 1 is the compass.


Goal 1: National policy that addresses the needs of patients living with allergic disease

Goal 1 establishes the national policy foundations that allow the other goals to succeed. In practice, that means: coordinated leadership across the UK, closing key policy and legislative gaps, and strengthening accountability, investigation and learning from allergic harm. 


The key outcomes Goal 1 is aiming to achieve

1) A UK-wide Strategic Framework for Allergy, supported by all four governments
At the heart of Goal 1 is a commitment to treat allergic disease as a major long-term health condition within policy frameworks, with funding and accountability structures that match the scale of need. It also means ensuring that policies across sectors explicitly consider allergy and allergy-related outcomes — not as an afterthought, but as a standard expectation.

What this changes for patients: fewer “grey areas” where responsibility is unclear; less variation in safety standards and support depending on where someone lives; and a clearer sense that allergy is taken seriously as a national priority.

2) Visible leadership and infrastructure to deliver the strategy
Goal 1 proposes dedicated leadership — including a National Lead (often described as an “Allergy Tsar”) embedded in the Department of Health and Social Care, with equivalent leads in each devolved government — alongside cross-sector governance structures and expert groups to drive delivery, align standards, and identify regulatory gaps. It also emphasises investing in the infrastructure and people required to implement change.

What this changes for patients: faster progress, fewer stalled recommendations, and a stronger guarantee that “what should happen” actually does happen — because someone is responsible for making it real.

3) Stronger protections and safer, more inclusive education settings
For many families, school is where allergy risk feels most intense — because a child cannot control their environment in the way an adult can. Goal 1 prioritises statutory, enforceable standards for allergy management in educational settings, backed by proper staff training and access to emergency medication. It also supports adoption of “Benedict’s Law”, including requirements for allergy policies in schools, staff training, and funded spare adrenaline devices for emergencies and the vote for the amendment to include this in the Child and Wellbeing Bill in February was an important step towards this. Goal 1 also proposes recognising severe allergy as a safeguarding issue, so that children and young people with severe allergies are treated as a vulnerable group within statutory guidance.

What this changes for patients and families: children with allergies being safer in schools – fewer avoidable emergencies; faster, more confident responses when reactions happen; reduced pressure on parents to “solve” systemic gaps; and a stronger expectation that children can participate fully and safely at school.

4) Safer food environments — especially when eating out
Eating out should not feel like a high-stakes negotiation. Goal 1 highlights the need to strengthen food allergen information in hospitality settings through “Owen’s Law” and to improve training and communication, including ideas such as a national “hospitality skills” passport to support consistent allergen awareness in a high-turnover workforce. It also addresses the need for better reporting and learning from serious community allergic reactions, strengthening consumer confidence and public protection.
What this changes for patients: clearer information, fewer “you have to ask” moments, fewer dangerous misunderstandings, and more freedom to take part in social life without fear.

5) Better national reporting, investigation and learning from allergic harm
A key theme of Goal 1 is accountability: learning from severe reactions and deaths so the same preventable failures don’t repeat. It proposes mechanisms such as mandated reporting of anaphylaxis presenting to healthcare settings and reporting of allergic reactions and near-misses in educational settings, alongside stronger expectations around investigation and follow-up learning.
What this changes for patients: fewer repeated system failures, earlier warning when risks are emerging, and a culture that treats allergic harm with the seriousness it deserves.

6) Reducing harm from drug allergy — including mislabelling
Many people carry a “drug allergy” label that is never revisited, and that can lead to poorer treatment choices and unnecessary healthcare costs. Goal 1 proposes a nationally coordinated approach to improve recording and support effective “delabelling” where appropriate — particularly for penicillin allergy — aligning this work with wider health priorities such as antimicrobial stewardship.

What this changes for patients: safer prescribing, fewer avoidable side effects from alternative medicines, and better treatment outcomes.

Anaphlaxis

Why Goal 1 matters: from policy to everyday life

Policy can feel distant — but for allergy, it is often the difference between safety and risk. Our strategy around policy is designed to make safety reliable rather than optional: clear responsibilities, enforceable standards, and learning systems that prevent recurrence. It underpins the strategy’s broader vision to reduce the burden of allergic disease, improve quality of life, and tackle inequalities across the UK.

If implemented, this means fewer families living in a constant state of vigilance, fewer people excluded from normal activities, and fewer emergencies that should never have happened. Most importantly, it builds the national leadership and accountability needed so that improvements in healthcare, prevention, awareness and research (the other goals) can be delivered consistently — not just in the best-served areas, but for everyone.

A National Allergy Strategy is, at its heart, a promise: that living with allergy should not mean living with avoidable danger, avoidable disadvantage, or avoidable fear. It is transformation around policy where that promise becomes a practical plan.